ATS 2020 Advance Program

Empowerment Collaborations to Reduce Childhood Asthma Disparities program. The clinical trials involve multi-level interventions targeted to address the needs of the communities where they are conducted. The presenters will discuss their experience in 4 different communities to date, including their observations regarding the barriers and facilitators to their efforts to engage communities and schools as well as considerations for integrating asthma interventions within schools and working with community health workers (CHW). Chairing: M.M. Freemer, MD, MPH, Bethesda, MD 12:15 Steps Toward Initiating Community Engagement and Sustaining It: Lessons Learned B.G. Bender, PhD, Denver, CO 12:23 Steps Toward Initiating Community Engagement and Sustaining It: Lessons Learned L.B. Gerald, PhD, MSPH, Tucson, AZ 12:30 School Engagement in Community Asthma Programs R.S. Everhart, PhD, Richmond, VA 12:45 Implementing Asthma Interventions in Schools- Public and Charter: Lessons Learned T. Bryant-Stephens, MD, Philadelphia, PA 1:00 Integrating and Engaging Community Health Workers into Asthma Implementation Research: Lessons Learned E. McQuaid, PhD, Providence, RI 1:08 Integrating and Engaging Community Health Workers into Asthma Implementation Research: Lessons Learned D. Koinis-Mitchell, PhD, Providence, RI DIVISION OF LUNG DISEASES/NHLBI L19 NHLBI PREVENTION AND EARLY TREATMENT OF ACUTE LUNG INJURY (PETAL) NETWORK 12:15 p.m. - 1:15 p.m. Target Audience Practicing critical care and emergency medicine clinicians and clinical researchers would benefit from this session. This includes fellows, students, nurses, and other medical professionals. Objectives At the conclusion of this session, the participant will be able to: • understand the goals and structure of the PETAL network; • understand the questions being addressed in PETAL and the design/conducts of the trials; • learn new findings and results of PETAL studies. This session will provide an update on the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) clinical trials network. The session will describe the structure and goals of the PETAL network, an overview of progress in ongoing trials, opportunities for additional studies using PETAL data and biospecimens, and results of studies to date. Chairing: L. Reineck, MD, Bethesda, MD R.G. Brower, MD, Baltimore, MD 12:15 PETAL Overview R.G. Brower, MD, Baltimore, MD 12:20 Vitamin D (VIOLET) Trial Results A. Ginde, MD, MPH, Aurora, CO 12:30 Update on the CLOVERS Trial I.S. Douglas, MD, Denver, CO 12:40 Introducing the ASTER Trial M.A. Matthay, MD, San Francisco, CA 12:50 Extending PETAL Science Through Ancillary Studies R. Baron, MD, Boston, MA ATS 2020 • Philadelphia, PA MONDAY • MAY 18 83